Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

NCT00152308 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

333

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrolement

Conditions

Coronary Disease

Interventions

DEVICE: 2% rapamycin-eluting YUKONdes PEARL-stent
DEVICE: 1% rapamycin-eluting YUKONdes PEARL-stent
DEVICE: YUKONdes PEARL-stent coated with placebo (ethanol)

Sponsor

Translumina GmbH